Release of serotonin from nerve endings by l-5-hydroxytryptophan, α-methyl-m-tyramine, and elevated potassium ions

W. J. McBride, M. H. Aprison

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The release of [3H]5-hydroxytryptamine ([3H]5-HT) by l-5-hydroxytryptophan (L-5-HTP), α-methyl-m-tyramine (α-MMTA), and elevated levels of K+ was studied using crude synaptosomal preparations (P2) isolated from the telencephalon of the rat and pigeon. Studies were conducted in vitro in the presence of either 2×10-5 M tranylcypromine, which inhibited the MAO activity of both the extrasynaptosomal mitochondria and the mitochondria contained within the nerve endings (intrasynaptosomal mitochondria), or 2×10-5 M nialamide, which inhibited the MAO activity of the extrasynaptosomal mitochondria under the experimental conditions used. In the P2 fraction isolated from the rat, either 55 mM K+, 0.10 mM l-5-HTP, or 0.03 mM α-MMTA significantly increased the release of [3H]5-HT above control levels, regardless of which MAO inhibitor was present in the medium. In the presence of tranylcypromine, this increased release by 55 mM K+ or 0.10 mM l-5-HTP was partially suppressed if Ca2+ was omitted from the medium. In the presence of nialamide, the release by 55 mM K+ was completely prevented if Ca2+ was omitted; the release by l-5-HTP was only partially affected. The release of [3H]5-HT by α-MMTA did not appear to be markedly affected by removal of Ca2+, regardless of which MAO inhibitor was present. Very similar data were obtained in the presence of nialamide using the P2 fraction isolated from the telencephalon of the pigeon, with the exception that 0.10 mM l-5-HTP caused an increase in the release of [3H]5-HIAA (which was not calcium-dependent) instead of [3H]5-HT. The data are discussed in

Original languageEnglish
Pages (from-to)233-249
Number of pages17
JournalNeurochemical Research
Volume1
Issue number3
DOIs
StatePublished - Jun 1976

Fingerprint

5-Hydroxytryptophan
Nerve Endings
Mitochondria
Nialamide
Serotonin
Potassium
Ions
Tranylcypromine
Telencephalon
Monoamine Oxidase Inhibitors
Monoamine Oxidase
Columbidae
Rats
Hydroxyindoleacetic Acid
Level control
3-tyramine
Calcium

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry

Cite this

Release of serotonin from nerve endings by l-5-hydroxytryptophan, α-methyl-m-tyramine, and elevated potassium ions. / McBride, W. J.; Aprison, M. H.

In: Neurochemical Research, Vol. 1, No. 3, 06.1976, p. 233-249.

Research output: Contribution to journalArticle

@article{fe07e178fcb34c13adeef344dea7e32f,
title = "Release of serotonin from nerve endings by l-5-hydroxytryptophan, α-methyl-m-tyramine, and elevated potassium ions",
abstract = "The release of [3H]5-hydroxytryptamine ([3H]5-HT) by l-5-hydroxytryptophan (L-5-HTP), α-methyl-m-tyramine (α-MMTA), and elevated levels of K+ was studied using crude synaptosomal preparations (P2) isolated from the telencephalon of the rat and pigeon. Studies were conducted in vitro in the presence of either 2×10-5 M tranylcypromine, which inhibited the MAO activity of both the extrasynaptosomal mitochondria and the mitochondria contained within the nerve endings (intrasynaptosomal mitochondria), or 2×10-5 M nialamide, which inhibited the MAO activity of the extrasynaptosomal mitochondria under the experimental conditions used. In the P2 fraction isolated from the rat, either 55 mM K+, 0.10 mM l-5-HTP, or 0.03 mM α-MMTA significantly increased the release of [3H]5-HT above control levels, regardless of which MAO inhibitor was present in the medium. In the presence of tranylcypromine, this increased release by 55 mM K+ or 0.10 mM l-5-HTP was partially suppressed if Ca2+ was omitted from the medium. In the presence of nialamide, the release by 55 mM K+ was completely prevented if Ca2+ was omitted; the release by l-5-HTP was only partially affected. The release of [3H]5-HT by α-MMTA did not appear to be markedly affected by removal of Ca2+, regardless of which MAO inhibitor was present. Very similar data were obtained in the presence of nialamide using the P2 fraction isolated from the telencephalon of the pigeon, with the exception that 0.10 mM l-5-HTP caused an increase in the release of [3H]5-HIAA (which was not calcium-dependent) instead of [3H]5-HT. The data are discussed in",
author = "McBride, {W. J.} and Aprison, {M. H.}",
year = "1976",
month = "6",
doi = "10.1007/BF00973771",
language = "English",
volume = "1",
pages = "233--249",
journal = "Neurochemical Research",
issn = "0364-3190",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Release of serotonin from nerve endings by l-5-hydroxytryptophan, α-methyl-m-tyramine, and elevated potassium ions

AU - McBride, W. J.

AU - Aprison, M. H.

PY - 1976/6

Y1 - 1976/6

N2 - The release of [3H]5-hydroxytryptamine ([3H]5-HT) by l-5-hydroxytryptophan (L-5-HTP), α-methyl-m-tyramine (α-MMTA), and elevated levels of K+ was studied using crude synaptosomal preparations (P2) isolated from the telencephalon of the rat and pigeon. Studies were conducted in vitro in the presence of either 2×10-5 M tranylcypromine, which inhibited the MAO activity of both the extrasynaptosomal mitochondria and the mitochondria contained within the nerve endings (intrasynaptosomal mitochondria), or 2×10-5 M nialamide, which inhibited the MAO activity of the extrasynaptosomal mitochondria under the experimental conditions used. In the P2 fraction isolated from the rat, either 55 mM K+, 0.10 mM l-5-HTP, or 0.03 mM α-MMTA significantly increased the release of [3H]5-HT above control levels, regardless of which MAO inhibitor was present in the medium. In the presence of tranylcypromine, this increased release by 55 mM K+ or 0.10 mM l-5-HTP was partially suppressed if Ca2+ was omitted from the medium. In the presence of nialamide, the release by 55 mM K+ was completely prevented if Ca2+ was omitted; the release by l-5-HTP was only partially affected. The release of [3H]5-HT by α-MMTA did not appear to be markedly affected by removal of Ca2+, regardless of which MAO inhibitor was present. Very similar data were obtained in the presence of nialamide using the P2 fraction isolated from the telencephalon of the pigeon, with the exception that 0.10 mM l-5-HTP caused an increase in the release of [3H]5-HIAA (which was not calcium-dependent) instead of [3H]5-HT. The data are discussed in

AB - The release of [3H]5-hydroxytryptamine ([3H]5-HT) by l-5-hydroxytryptophan (L-5-HTP), α-methyl-m-tyramine (α-MMTA), and elevated levels of K+ was studied using crude synaptosomal preparations (P2) isolated from the telencephalon of the rat and pigeon. Studies were conducted in vitro in the presence of either 2×10-5 M tranylcypromine, which inhibited the MAO activity of both the extrasynaptosomal mitochondria and the mitochondria contained within the nerve endings (intrasynaptosomal mitochondria), or 2×10-5 M nialamide, which inhibited the MAO activity of the extrasynaptosomal mitochondria under the experimental conditions used. In the P2 fraction isolated from the rat, either 55 mM K+, 0.10 mM l-5-HTP, or 0.03 mM α-MMTA significantly increased the release of [3H]5-HT above control levels, regardless of which MAO inhibitor was present in the medium. In the presence of tranylcypromine, this increased release by 55 mM K+ or 0.10 mM l-5-HTP was partially suppressed if Ca2+ was omitted from the medium. In the presence of nialamide, the release by 55 mM K+ was completely prevented if Ca2+ was omitted; the release by l-5-HTP was only partially affected. The release of [3H]5-HT by α-MMTA did not appear to be markedly affected by removal of Ca2+, regardless of which MAO inhibitor was present. Very similar data were obtained in the presence of nialamide using the P2 fraction isolated from the telencephalon of the pigeon, with the exception that 0.10 mM l-5-HTP caused an increase in the release of [3H]5-HIAA (which was not calcium-dependent) instead of [3H]5-HT. The data are discussed in

UR - http://www.scopus.com/inward/record.url?scp=34250384985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250384985&partnerID=8YFLogxK

U2 - 10.1007/BF00973771

DO - 10.1007/BF00973771

M3 - Article

C2 - 24271411

AN - SCOPUS:34250384985

VL - 1

SP - 233

EP - 249

JO - Neurochemical Research

JF - Neurochemical Research

SN - 0364-3190

IS - 3

ER -